Global Irbesartan Market Insights and Forecast to 2028

Global Irbesartan Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Irbesartan Product Introduction
1.2 Market by Type
1.2.1 Global Irbesartan Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Combination Drugs
1.2.3 Prescribed Drugs
1.3 Market by Application
1.3.1 Global Irbesartan Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hyperlipidemia
1.3.3 High Blood Pressure
1.3.4 Heart Failure
1.3.5 Kidney Disease
1.3.6 Fibrous Fibrillation
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Irbesartan Sales Estimates and Forecasts 2017-2028
2.2 Global Irbesartan Revenue Estimates and Forecasts 2017-2028
2.3 Global Irbesartan Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Irbesartan Sales by Region
2.4.1 Global Irbesartan Sales by Region (2017-2022)
2.4.2 Global Sales Irbesartan by Region (2023-2028)
2.5 Global Irbesartan Revenue by Region
2.5.1 Global Irbesartan Revenue by Region (2017-2022)
2.5.2 Global Irbesartan Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Irbesartan Sales by Manufacturers
3.1.1 Global Top Irbesartan Manufacturers by Sales (2017-2022)
3.1.2 Global Irbesartan Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Irbesartan in 2021
3.2 Global Irbesartan Revenue by Manufacturers
3.2.1 Global Irbesartan Revenue by Manufacturers (2017-2022)
3.2.2 Global Irbesartan Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Irbesartan Revenue in 2021
3.3 Global Irbesartan Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Irbesartan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Irbesartan Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Irbesartan Sales by Type
4.1.1 Global Irbesartan Historical Sales by Type (2017-2022)
4.1.2 Global Irbesartan Forecasted Sales by Type (2023-2028)
4.1.3 Global Irbesartan Sales Market Share by Type (2017-2028)
4.2 Global Irbesartan Revenue by Type
4.2.1 Global Irbesartan Historical Revenue by Type (2017-2022)
4.2.2 Global Irbesartan Forecasted Revenue by Type (2023-2028)
4.2.3 Global Irbesartan Revenue Market Share by Type (2017-2028)
4.3 Global Irbesartan Price by Type
4.3.1 Global Irbesartan Price by Type (2017-2022)
4.3.2 Global Irbesartan Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Irbesartan Sales by Application
5.1.1 Global Irbesartan Historical Sales by Application (2017-2022)
5.1.2 Global Irbesartan Forecasted Sales by Application (2023-2028)
5.1.3 Global Irbesartan Sales Market Share by Application (2017-2028)
5.2 Global Irbesartan Revenue by Application
5.2.1 Global Irbesartan Historical Revenue by Application (2017-2022)
5.2.2 Global Irbesartan Forecasted Revenue by Application (2023-2028)
5.2.3 Global Irbesartan Revenue Market Share by Application (2017-2028)
5.3 Global Irbesartan Price by Application
5.3.1 Global Irbesartan Price by Application (2017-2022)
5.3.2 Global Irbesartan Price Forecast by Application (2023-2028)
6 North America
6.1 North America Irbesartan Market Size by Type
6.1.1 North America Irbesartan Sales by Type (2017-2028)
6.1.2 North America Irbesartan Revenue by Type (2017-2028)
6.2 North America Irbesartan Market Size by Application
6.2.1 North America Irbesartan Sales by Application (2017-2028)
6.2.2 North America Irbesartan Revenue by Application (2017-2028)
6.3 North America Irbesartan Market Size by Country
6.3.1 North America Irbesartan Sales by Country (2017-2028)
6.3.2 North America Irbesartan Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Irbesartan Market Size by Type
7.1.1 Europe Irbesartan Sales by Type (2017-2028)
7.1.2 Europe Irbesartan Revenue by Type (2017-2028)
7.2 Europe Irbesartan Market Size by Application
7.2.1 Europe Irbesartan Sales by Application (2017-2028)
7.2.2 Europe Irbesartan Revenue by Application (2017-2028)
7.3 Europe Irbesartan Market Size by Country
7.3.1 Europe Irbesartan Sales by Country (2017-2028)
7.3.2 Europe Irbesartan Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Irbesartan Market Size by Type
8.1.1 Asia Pacific Irbesartan Sales by Type (2017-2028)
8.1.2 Asia Pacific Irbesartan Revenue by Type (2017-2028)
8.2 Asia Pacific Irbesartan Market Size by Application
8.2.1 Asia Pacific Irbesartan Sales by Application (2017-2028)
8.2.2 Asia Pacific Irbesartan Revenue by Application (2017-2028)
8.3 Asia Pacific Irbesartan Market Size by Region
8.3.1 Asia Pacific Irbesartan Sales by Region (2017-2028)
8.3.2 Asia Pacific Irbesartan Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Irbesartan Market Size by Type
9.1.1 Latin America Irbesartan Sales by Type (2017-2028)
9.1.2 Latin America Irbesartan Revenue by Type (2017-2028)
9.2 Latin America Irbesartan Market Size by Application
9.2.1 Latin America Irbesartan Sales by Application (2017-2028)
9.2.2 Latin America Irbesartan Revenue by Application (2017-2028)
9.3 Latin America Irbesartan Market Size by Country
9.3.1 Latin America Irbesartan Sales by Country (2017-2028)
9.3.2 Latin America Irbesartan Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Irbesartan Market Size by Type
10.1.1 Middle East and Africa Irbesartan Sales by Type (2017-2028)
10.1.2 Middle East and Africa Irbesartan Revenue by Type (2017-2028)
10.2 Middle East and Africa Irbesartan Market Size by Application
10.2.1 Middle East and Africa Irbesartan Sales by Application (2017-2028)
10.2.2 Middle East and Africa Irbesartan Revenue by Application (2017-2028)
10.3 Middle East and Africa Irbesartan Market Size by Country
10.3.1 Middle East and Africa Irbesartan Sales by Country (2017-2028)
10.3.2 Middle East and Africa Irbesartan Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Overview
11.1.3 Teva Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Teva Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 BMS
11.3.1 BMS Corporation Information
11.3.2 BMS Overview
11.3.3 BMS Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 BMS Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BMS Recent Developments
11.4 Sumitomo Dainippon Pharma
11.4.1 Sumitomo Dainippon Pharma Corporation Information
11.4.2 Sumitomo Dainippon Pharma Overview
11.4.3 Sumitomo Dainippon Pharma Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sumitomo Dainippon Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sumitomo Dainippon Pharma Recent Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Overview
11.5.3 Novartis Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novartis Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Shionogi
11.6.1 Shionogi Corporation Information
11.6.2 Shionogi Overview
11.6.3 Shionogi Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Shionogi Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Shionogi Recent Developments
11.7 Hanall
11.7.1 Hanall Corporation Information
11.7.2 Hanall Overview
11.7.3 Hanall Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hanall Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hanall Recent Developments
11.8 Taj Pharmaceuticals
11.8.1 Taj Pharmaceuticals Corporation Information
11.8.2 Taj Pharmaceuticals Overview
11.8.3 Taj Pharmaceuticals Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Taj Pharmaceuticals Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Taj Pharmaceuticals Recent Developments
11.9 Apotex
11.9.1 Apotex Corporation Information
11.9.2 Apotex Overview
11.9.3 Apotex Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Apotex Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Apotex Recent Developments
11.10 Jiangsu Hengrui Medicine
11.10.1 Jiangsu Hengrui Medicine Corporation Information
11.10.2 Jiangsu Hengrui Medicine Overview
11.10.3 Jiangsu Hengrui Medicine Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Jiangsu Hengrui Medicine Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Jiangsu Hengrui Medicine Recent Developments
11.11 Verdant Life Sciences
11.11.1 Verdant Life Sciences Corporation Information
11.11.2 Verdant Life Sciences Overview
11.11.3 Verdant Life Sciences Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Verdant Life Sciences Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Verdant Life Sciences Recent Developments
11.12 Angita Pharma
11.12.1 Angita Pharma Corporation Information
11.12.2 Angita Pharma Overview
11.12.3 Angita Pharma Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Angita Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Angita Pharma Recent Developments
11.13 Auro Pharma
11.13.1 Auro Pharma Corporation Information
11.13.2 Auro Pharma Overview
11.13.3 Auro Pharma Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Auro Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Auro Pharma Recent Developments
11.14 Avanstra
11.14.1 Avanstra Corporation Information
11.14.2 Avanstra Overview
11.14.3 Avanstra Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Avanstra Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Avanstra Recent Developments
11.15 Zhuhai Rundu Pharma
11.15.1 Zhuhai Rundu Pharma Corporation Information
11.15.2 Zhuhai Rundu Pharma Overview
11.15.3 Zhuhai Rundu Pharma Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Zhuhai Rundu Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Zhuhai Rundu Pharma Recent Developments
11.16 Xiansheng Pharmaceutical
11.16.1 Xiansheng Pharmaceutical Corporation Information
11.16.2 Xiansheng Pharmaceutical Overview
11.16.3 Xiansheng Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Xiansheng Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Xiansheng Pharmaceutical Recent Developments
11.17 CTTQ
11.17.1 CTTQ Corporation Information
11.17.2 CTTQ Overview
11.17.3 CTTQ Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 CTTQ Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 CTTQ Recent Developments
11.18 Tianjin Huairen Pharmaceutical
11.18.1 Tianjin Huairen Pharmaceutical Corporation Information
11.18.2 Tianjin Huairen Pharmaceutical Overview
11.18.3 Tianjin Huairen Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Tianjin Huairen Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Tianjin Huairen Pharmaceutical Recent Developments
11.19 Jiangsu Wangao Pharmaceutical
11.19.1 Jiangsu Wangao Pharmaceutical Corporation Information
11.19.2 Jiangsu Wangao Pharmaceutical Overview
11.19.3 Jiangsu Wangao Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Jiangsu Wangao Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Jiangsu Wangao Pharmaceutical Recent Developments
11.20 Zhejiang Huahai Pharmaceutical
11.20.1 Zhejiang Huahai Pharmaceutical Corporation Information
11.20.2 Zhejiang Huahai Pharmaceutical Overview
11.20.3 Zhejiang Huahai Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Zhejiang Huahai Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Zhejiang Huahai Pharmaceutical Recent Developments
11.21 Zhejiang Ainuo Pharmaceutical
11.21.1 Zhejiang Ainuo Pharmaceutical Corporation Information
11.21.2 Zhejiang Ainuo Pharmaceutical Overview
11.21.3 Zhejiang Ainuo Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Zhejiang Ainuo Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Zhejiang Ainuo Pharmaceutical Recent Developments
11.22 Yuanhe Pharmaceutical
11.22.1 Yuanhe Pharmaceutical Corporation Information
11.22.2 Yuanhe Pharmaceutical Overview
11.22.3 Yuanhe Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Yuanhe Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Yuanhe Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Irbesartan Industry Chain Analysis
12.2 Irbesartan Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Irbesartan Production Mode & Process
12.4 Irbesartan Sales and Marketing
12.4.1 Irbesartan Sales Channels
12.4.2 Irbesartan Distributors
12.5 Irbesartan Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Irbesartan Industry Trends
13.2 Irbesartan Market Drivers
13.3 Irbesartan Market Challenges
13.4 Irbesartan Market Restraints
14 Key Findings in The Global Irbesartan Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Irbesartan Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Combination Drugs
Table 3. Major Manufacturers of Prescribed Drugs
Table 4. Global Irbesartan Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Irbesartan Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Irbesartan Sales by Region (2017-2022) & (KG)
Table 7. Global Irbesartan Sales Market Share by Region (2017-2022)
Table 8. Global Irbesartan Sales by Region (2023-2028) & (KG)
Table 9. Global Irbesartan Sales Market Share by Region (2023-2028)
Table 10. Global Irbesartan Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Irbesartan Revenue Market Share by Region (2017-2022)
Table 12. Global Irbesartan Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Irbesartan Revenue Market Share by Region (2023-2028)
Table 14. Global Irbesartan Sales by Manufacturers (2017-2022) & (KG)
Table 15. Global Irbesartan Sales Share by Manufacturers (2017-2022)
Table 16. Global Irbesartan Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Irbesartan Revenue Share by Manufacturers (2017-2022)
Table 18. Irbesartan Price by Manufacturers (2017-2022) &(US$/G)
Table 19. Global Irbesartan Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Irbesartan by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irbesartan as of 2021)
Table 21. Irbesartan Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Irbesartan Product Offered
Table 23. Date of Manufacturers Enter into Irbesartan Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Irbesartan Sales by Type (2017-2022) & (KG)
Table 26. Global Irbesartan Sales by Type (2023-2028) & (KG)
Table 27. Global Irbesartan Sales Share by Type (2017-2022)
Table 28. Global Irbesartan Sales Share by Type (2023-2028)
Table 29. Global Irbesartan Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Irbesartan Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Irbesartan Revenue Share by Type (2017-2022)
Table 32. Global Irbesartan Revenue Share by Type (2023-2028)
Table 33. Irbesartan Price by Type (2017-2022) & (US$/G)
Table 34. Global Irbesartan Price Forecast by Type (2023-2028) & (US$/G)
Table 35. Global Irbesartan Sales by Application (2017-2022) & (KG)
Table 36. Global Irbesartan Sales by Application (2023-2028) & (KG)
Table 37. Global Irbesartan Sales Share by Application (2017-2022)
Table 38. Global Irbesartan Sales Share by Application (2023-2028)
Table 39. Global Irbesartan Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Irbesartan Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Irbesartan Revenue Share by Application (2017-2022)
Table 42. Global Irbesartan Revenue Share by Application (2023-2028)
Table 43. Irbesartan Price by Application (2017-2022) & (US$/G)
Table 44. Global Irbesartan Price Forecast by Application (2023-2028) & (US$/G)
Table 45. North America Irbesartan Sales by Type (2017-2022) & (KG)
Table 46. North America Irbesartan Sales by Type (2023-2028) & (KG)
Table 47. North America Irbesartan Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Irbesartan Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Irbesartan Sales by Application (2017-2022) & (KG)
Table 50. North America Irbesartan Sales by Application (2023-2028) & (KG)
Table 51. North America Irbesartan Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Irbesartan Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Irbesartan Sales by Country (2017-2022) & (KG)
Table 54. North America Irbesartan Sales by Country (2023-2028) & (KG)
Table 55. North America Irbesartan Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Irbesartan Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Irbesartan Sales by Type (2017-2022) & (KG)
Table 58. Europe Irbesartan Sales by Type (2023-2028) & (KG)
Table 59. Europe Irbesartan Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Irbesartan Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Irbesartan Sales by Application (2017-2022) & (KG)
Table 62. Europe Irbesartan Sales by Application (2023-2028) & (KG)
Table 63. Europe Irbesartan Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Irbesartan Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Irbesartan Sales by Country (2017-2022) & (KG)
Table 66. Europe Irbesartan Sales by Country (2023-2028) & (KG)
Table 67. Europe Irbesartan Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Irbesartan Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Irbesartan Sales by Type (2017-2022) & (KG)
Table 70. Asia Pacific Irbesartan Sales by Type (2023-2028) & (KG)
Table 71. Asia Pacific Irbesartan Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Irbesartan Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Irbesartan Sales by Application (2017-2022) & (KG)
Table 74. Asia Pacific Irbesartan Sales by Application (2023-2028) & (KG)
Table 75. Asia Pacific Irbesartan Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Irbesartan Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Irbesartan Sales by Region (2017-2022) & (KG)
Table 78. Asia Pacific Irbesartan Sales by Region (2023-2028) & (KG)
Table 79. Asia Pacific Irbesartan Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Irbesartan Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Irbesartan Sales by Type (2017-2022) & (KG)
Table 82. Latin America Irbesartan Sales by Type (2023-2028) & (KG)
Table 83. Latin America Irbesartan Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Irbesartan Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Irbesartan Sales by Application (2017-2022) & (KG)
Table 86. Latin America Irbesartan Sales by Application (2023-2028) & (KG)
Table 87. Latin America Irbesartan Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Irbesartan Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Irbesartan Sales by Country (2017-2022) & (KG)
Table 90. Latin America Irbesartan Sales by Country (2023-2028) & (KG)
Table 91. Latin America Irbesartan Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Irbesartan Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Irbesartan Sales by Type (2017-2022) & (KG)
Table 94. Middle East and Africa Irbesartan Sales by Type (2023-2028) & (KG)
Table 95. Middle East and Africa Irbesartan Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Irbesartan Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Irbesartan Sales by Application (2017-2022) & (KG)
Table 98. Middle East and Africa Irbesartan Sales by Application (2023-2028) & (KG)
Table 99. Middle East and Africa Irbesartan Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Irbesartan Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Irbesartan Sales by Country (2017-2022) & (KG)
Table 102. Middle East and Africa Irbesartan Sales by Country (2023-2028) & (KG)
Table 103. Middle East and Africa Irbesartan Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Irbesartan Revenue by Country (2023-2028) & (US$ Million)
Table 105. Teva Corporation Information
Table 106. Teva Description and Major Businesses
Table 107. Teva Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 108. Teva Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Teva Recent Developments
Table 110. Sanofi Corporation Information
Table 111. Sanofi Description and Major Businesses
Table 112. Sanofi Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 113. Sanofi Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Sanofi Recent Developments
Table 115. BMS Corporation Information
Table 116. BMS Description and Major Businesses
Table 117. BMS Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 118. BMS Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. BMS Recent Developments
Table 120. Sumitomo Dainippon Pharma Corporation Information
Table 121. Sumitomo Dainippon Pharma Description and Major Businesses
Table 122. Sumitomo Dainippon Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 123. Sumitomo Dainippon Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Sumitomo Dainippon Pharma Recent Developments
Table 125. Novartis Corporation Information
Table 126. Novartis Description and Major Businesses
Table 127. Novartis Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 128. Novartis Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Novartis Recent Developments
Table 130. Shionogi Corporation Information
Table 131. Shionogi Description and Major Businesses
Table 132. Shionogi Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 133. Shionogi Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Shionogi Recent Developments
Table 135. Hanall Corporation Information
Table 136. Hanall Description and Major Businesses
Table 137. Hanall Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 138. Hanall Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Hanall Recent Developments
Table 140. Taj Pharmaceuticals Corporation Information
Table 141. Taj Pharmaceuticals Description and Major Businesses
Table 142. Taj Pharmaceuticals Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 143. Taj Pharmaceuticals Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Taj Pharmaceuticals Recent Developments
Table 145. Apotex Corporation Information
Table 146. Apotex Description and Major Businesses
Table 147. Apotex Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 148. Apotex Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Apotex Recent Developments
Table 150. Jiangsu Hengrui Medicine Corporation Information
Table 151. Jiangsu Hengrui Medicine Description and Major Businesses
Table 152. Jiangsu Hengrui Medicine Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 153. Jiangsu Hengrui Medicine Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Jiangsu Hengrui Medicine Recent Developments
Table 155. Verdant Life Sciences Corporation Information
Table 156. Verdant Life Sciences Description and Major Businesses
Table 157. Verdant Life Sciences Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 158. Verdant Life Sciences Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Verdant Life Sciences Recent Developments
Table 160. Angita Pharma Corporation Information
Table 161. Angita Pharma Description and Major Businesses
Table 162. Angita Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 163. Angita Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Angita Pharma Recent Developments
Table 165. Auro Pharma Corporation Information
Table 166. Auro Pharma Description and Major Businesses
Table 167. Auro Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 168. Auro Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Auro Pharma Recent Developments
Table 170. Avanstra Corporation Information
Table 171. Avanstra Description and Major Businesses
Table 172. Avanstra Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 173. Avanstra Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Avanstra Recent Developments
Table 175. Zhuhai Rundu Pharma Corporation Information
Table 176. Zhuhai Rundu Pharma Description and Major Businesses
Table 177. Zhuhai Rundu Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 178. Zhuhai Rundu Pharma Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Zhuhai Rundu Pharma Recent Developments
Table 180. Xiansheng Pharmaceutical Corporation Information
Table 181. Xiansheng Pharmaceutical Description and Major Businesses
Table 182. Xiansheng Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 183. Xiansheng Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Xiansheng Pharmaceutical Recent Developments
Table 185. CTTQ Corporation Information
Table 186. CTTQ Description and Major Businesses
Table 187. CTTQ Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 188. CTTQ Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. CTTQ Recent Developments
Table 190. Tianjin Huairen Pharmaceutical Corporation Information
Table 191. Tianjin Huairen Pharmaceutical Description and Major Businesses
Table 192. Tianjin Huairen Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 193. Tianjin Huairen Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Tianjin Huairen Pharmaceutical Recent Developments
Table 195. Jiangsu Wangao Pharmaceutical Corporation Information
Table 196. Jiangsu Wangao Pharmaceutical Description and Major Businesses
Table 197. Jiangsu Wangao Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 198. Jiangsu Wangao Pharmaceutical Irbesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. Jiangsu Wangao Pharmaceutical Recent Developments
Table 200. Zhejiang Huahai Pharmaceutical Corporation Information
Table 201. Zhejiang Huahai Pharmaceutical Description and Major Businesses
Table 202. Zhejiang Huahai Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......

Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......

Global Amlodipine Besylate Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115

The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......

Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112

The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......

Captopril API - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100

The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......

Telmisartan - Global Market Insights and Sales Trends 2024

Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107

The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......

Global Ambrisentan Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106

Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......

Global Ambrisentan Market Research Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132

Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......

Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs